Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,356 | 34,814 | 29,429 | 39,143 | 43,836 |
| Marketable Securities | 696,925 | 388,784 | 275,523 | 369,107 | 150,586 |
| Receivables | 700 | 2,628 | 347 | 172 | 1,802 |
| TOTAL | $747,159 | $431,693 | $317,693 | $410,839 | $197,843 |
| Non-Current Assets | |||||
| PPE Net | 4,346 | 4,060 | 3,747 | 3,551 | 3,815 |
| Intangibles | 27,190 | 27,190 | 27,190 | 27,190 | 30,690 |
| Other Non-Current Assets | 13,645 | 2,684 | 4,105 | 3,074 | 3,490 |
| TOTAL | $45,181 | $33,934 | $35,042 | $33,815 | $37,995 |
| Total Assets | $792,340 | $465,627 | $352,735 | $444,654 | $235,838 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 942 | 3,988 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,265 | 3,494 | 3,340 | 1,228 | 1,048 |
| Accrued Expenses | 33,842 | 22,029 | 12,835 | 12,000 | 8,459 |
| Other current liabilities | N/A | N/A | 990 | 1,554 | 3,372 |
| TOTAL | $39,501 | $31,125 | $18,610 | $16,528 | $14,206 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 1,296 | N/A |
| Other Non-Current Liabilities | 5,834 | 5,331 | 7,921 | 7,354 | 12,275 |
| TOTAL | $5,834 | $5,331 | $7,921 | $8,650 | $12,275 |
| Total Liabilities | $45,335 | $36,456 | $26,531 | $25,178 | $26,481 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,384 | 55,901 | 47,207 | 46,735 | 39,615 |
| Common Shares | 66 | 56 | 47 | 47 | 40 |
| Retained earnings | -1,555,224 | -1,397,361 | -1,255,932 | -1,143,607 | -1,073,096 |
| Other shareholders' equity | 3,314 | 3,308 | 1,260 | 1,894 | 2,589 |
| TOTAL | $747,005 | $429,171 | $326,204 | $419,476 | $209,357 |
| Total Liabilities And Equity | $792,340 | $465,627 | $352,735 | $444,654 | $235,838 |